ipidomic changes in drug-naÃ¯ve/drug-free schizophrenia patients compared to healthy controls and itsassociation with clinical outcome: An observational study

Shivaprakash G0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Cases: Objective 1
•1. All diagnosed schizophrenia cases who are antipsychotic drug-free defined as 1 month for oral drugs and 3 months for injectable depots at the time of recruitment.
•2. Drug-naÃ¯ve schizophrenia cases diagnosed as per DSM- 5 by the psychiatrist, presenting at psychiatry department will be included.
•Control: The healthy control group, matched for age, gender [among the hospital staff and their family members and friends of same community with no personal and family history [I and II degree relatives] of psychotic illness.
•Objective 2 &3 :
•All drug-naÃ¯ve and drug-free SCZ patients diagnosed as per DSM 5 who were started with antipsychotic drugs

•Objective 1
•Metabolic syndrome and other medical disorders, acutely ill cases, cancer
•Patient on history of taking antipsychotics within last 1 month for oral drugs and 3 months for depot formulation, cholesterol lowering agents, substance abuse, immunomodulatory treatment
•Dietary supplementation with Polyunsaturated fatty acids or other lipids as therapy.
•Objective 2 and 3:
•Metabolic syndrome and other medical disorders, acutely ill cases, cancer
•Patient on cholesterol lowering agents, substance abuse, immunomodulatory treatment
•Dietary supplementation with Polyunsaturated fatty acids or other lipids as therapy

发起方

Shivaprakash G